de Araujo A, Alvares-da-Silva MR

Idioma: Ingles.
Referencias bibliográficas: 31
Paginas: 390-395
Archivo PDF: 91.51 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 142-53.

2. Runyon BA. Management of Adult Patients with Ascites Due to Cirrhosis: An Update. Hepatology 2009; 2087-107.

3. Garcia-Tsao G. Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis. Gastroenterology 2001; 726-48.

4. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012; 297-310.

5. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 397-417.

6. Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis: report on the 7th meeting of the international ascites club. Gut 2005; 54: 718-25.

7. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 1495-501.

8. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del- Arbol L, Castells L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 403-9.

9. de Araujo A, Lopes AB, Rossi G, da Silva GV, Ananias P, Ness S, Álvares-da-Silva MR. Low-dose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment? Gut 2012; 1371-2.

10. Ruiz-del-Arbol L, Urman J, Fernández J, Gonzáles M, Navasa M, Monescillo A, Albillos A, et al. Systemic, Renal, and Hepatic Hemodynamic Derangement in Cirrhotic Patients With Spontaneous Bacterial Peritonitis. Hepatology 2003; 1210-18.

11. Tandon P, Garcia-Tsao G. Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis. Semin Liver Dis 2008; 26-42.

12. Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: Current Management and future perspectives. J Hepatol 2010; 1135-45.

13. Koulaouzidis A, Bhat S, Saeed AA. Spontaneous bacterial peritonitis. World J Gastroenterol 2009; 1042-9.

14. Sigal SH, Stanca CM, Fernandez J, Arroio V, Navas M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 2007; 597-9.

15. Terg R, Gadano A, Cartier M, Ca sciato P, Lucero R, Munos R, Romero G, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int 2009; 415-9.

16. Salermo F, Gerbes A, Ginès P, Wong F, Arroio V. Diagnosis, prevention and treatment of Hepatorenal Syndrome in Cirrhosis. Gut 2007; 1310-18.

17. Ginès P, Schrier R. Renal Failure in Cirrhosis. N Eng J Med 2009; 1279-90.

18. Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010; 605-13.

19. Wong F, Nadim MK, Kellum JA, Salermo F, Bellomo R, Gerbes A, Angeli P, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 702-9.

20. de Carvalho JR, Villela-Nogueira CA, Luiz RR, Guzzo PL, da Silva Rosa JM, Rocha E, Moraes Coelho HD, et al. Acute Kidney Injury Network Criteria as a Predictor of Hospital Mortality in Cirrhotic Patients With Ascites. J Clin Gastroenterol 2012; 21-6.

21. Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, Coca SG, et al. Association of AKI With Mortality and Complications in Hospitalized Patients With Cirrhosis. Hepatology 2013; 753-62.

22. Huo T, Lin H, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, et al. Comparison of Four Model fo End-Stage Liver Disease- Based Prognostic Systems for Cirrhosis. Liv Transp 2008; 837-44.

23. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok ASF. Reweighting the Model for End-Stage Liver Disease Score Components. Gastroenterology 2008; 1575-81.

24. Freeman RB. Model for End-Stage Liver Disease (MELD) for Liver Allocation: A 5-Year Score Card. Hepatology 2008; 1052-7.

25. Volk ML, Lok ASF, Pelletier SJ, Ubel PA, Hayward RA. Impact of the Model for End-Stage Liver Disease Allocation Policy on the Use of High-Risk Organs for Liver Transplantation. Gastroenterology 2008; 135: 1568-74.

26. Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J,Brucner T, et al. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009; 72-8.

27. Cárdenas A, Ginès P. Acute-on-chronic liver failure: the kidneys. Current Opinion in Critical Care 2011; 184-9.

28. Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Current Opinion in Critical Care 2011; 165-9.

29. Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P. Acute Dialysis Quality Initiative Workgroup. Acute renal failuredefinition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 204-12.

30. Colongitas E, Calvaruso V, Senzolo M, Patch D, Shaw S, O’Beirne J, Burroughs AK, et al. RIFLE classification as predictive facter of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol and Hepatol 2009; 1639-47.

31. Jenq C, Tsai M, Tian Y, Lin CY, Yang C, Liu NJ, Lien JM, et al. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 2007; 1921-30.